Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group-Reference-Cited by-同舟云学术

Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group

Published:2000-02 Issue:2 Volume:76 Page:204-207
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Schilder Russell J.,Blessing John A.,Morgan Mark,Mangan Charles E.,Rader Janet S.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference24 articles.

1. Cancer statistics, 1998;Landis;CA Cancer J Clin,1998

2. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix;Thigpen;Semin Oncol,1995

3. Uterine Cervix;Perez,1992

4. DeLong, D, C, Hertel, L, W, Tang, J, Kroin, J, S, Wilson, J, D, Terry, J, Lavender, J, F, Antiviral activity of 2′,2′-difluorodeoxycytidine, Proc Ann Meet Am Soc Microbiol, Washington, DC, March 24–28, 1986

5. Induction of apoptosis by gemcitabine;Huang;Semin Oncol,1995

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Influence of Residual or Recurrent Disease on Bevacizumab Treatment Efficacy in Ovarian Cancer: Current Evidence and Future Perspectives;Cancers;2024-03-05

2. Chemotherapy for Advanced and Recurrent Cervical Cancer;Comprehensive Gynecology and Obstetrics;2024

3. Systemic therapy for advanced cervical cancer: Leveraging the historical threshold of overall survival;Critical Reviews in Oncology/Hematology;2023-03

4. Pembrolizumab monotherapy in heavily treated recurrent cervical cancer patients: case series report;European Journal of Gynaecological Oncology;2023

5. A review of the novel tissue factor antibody–drug conjugate: Tisotumab vedotin;Journal of Oncology Pharmacy Practice;2022-11-22